A recent study highlights a critical concern for patients using GLP-1 receptor agonists, such as Ozempic and Wegovy, revealing that discontinuing these medications can rapidly negate the cardiovascular benefits they provide. These drugs, widely prescribed for managing type 2 diabetes and promoting weight loss, have also been shown to significantly reduce the risk of heart…

Women who experience natural menopause before the age of 40 face a significantly higher risk of developing cardiovascular disease over their lifetime. According to recent research, premature menopause is linked to a 40% increase in the likelihood of coronary heart disease, highlighting the importance of early monitoring and preventive care for this group. Premature menopause,…